Bioorganic & Medicinal Chemistry 2009-10-01

Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.

Lei Du-Cuny, Zuohe Song, Sylvestor Moses, Garth Powis, Eugene A Mash, Emmanuelle J Meuillet, Shuxing Zhang, Lei Du-Cuny, Zuohe Song, Sylvestor Moses, Garth Powis, Eugene A. Mash, Emmanuelle J. Meuillet, Shuxing Zhang

Index: Bioorg. Med. Chem. 17 , 6983-92, (2009)

Full Text: HTML

Abstract

Computational modeling continues to play an important role in novel therapeutics discovery and development. In this study, we have investigated the use of in silico approaches to develop inhibitors of the pleckstrin homology (PH) domain of AKT (protein kinase B). Various docking/scoring schemes have been evaluated, and the best combination was selected to study the system. Using this strategy, two hits were identified and their binding behaviors were investigated. Robust and predictive QSAR models were built using the k nearest neighbor (kNN) method to study their cellular permeability. Based on our in silico results, long flexible aliphatic tails were proposed to improve the Caco-2 penetration without affecting the binding mode. The modifications enhanced the AKT inhibitory activity of the compounds in cell-based assays, and increased their activity as in vivo antitumor testing.

Related Compounds

Structure Name/CAS No. Articles
Hydrochlorothiazide Structure Hydrochlorothiazide
CAS:58-93-5
sucrose Structure sucrose
CAS:57-50-1
Piroxicam Structure Piroxicam
CAS:36322-90-4
beta-Estradiol Structure beta-Estradiol
CAS:50-28-2
Naproxen Structure Naproxen
CAS:22204-53-1
L-Nicotine Structure L-Nicotine
CAS:54-11-5
D-Mannitol Structure D-Mannitol
CAS:69-65-8
Salicylic acid Structure Salicylic acid
CAS:69-72-7
Sulpiride Structure Sulpiride
CAS:15676-16-1
Nitrendipine Structure Nitrendipine
CAS:39562-70-4